Brussels, Belgium (PRWEB) May 02, 2013
ISPE announced today that it will hold a conference on key challenges and opportunities in the pharmaceutical supply chain in Prague on 13-14 June 2013. This two-day event will cover critical-to-success factors in pharmaceutical supply chain management in investigational products and the commercial supply chain. Topics covered during the conference will include investigational product management / logistics, the commercial supply chain integrity and cargo risks. Special focus will be given to the EU GDP and GCP legislation and the Falsified Medicines Directive.
Jim McKiernan, CEO, McKiernan Associates, conference chair said, “The industry has made tremendous strides forward in the past decade to improve its supply chain efficiency. However, compared with other sectors, pharma still has a long way to go to achieve truly world-class performance. This conference will allow attendees to hear examples of best practice and gain insights on moving their business forward, as presented by leading practitioners and regulators.”
Esther Sadler-Williams, Senior Director, Catalent Pharma solutions and conference co-chair added, “The conference is organised by industry experts for experts and includes separate tracks specific to IP and supply chain. We will be covering key topics that explore the needs of our ultimate customer – the patient.”
The conference will provide a unique opportunity for supply chain and production plant managers, clinical supply professionals, CROs, CMOs, anti-counterfeiting officers and tech transfer specialists to be updated on the latest technological and regulatory developments in pharmaceutical supply chain operations. In total, more than 30 industry and regulatory speakers from organizations such as MHRA, NHS Scotland, Napp, Boehringer Ingelheim and Cemafroid, will share their knowledge and experience.
For more information on this conference, including detailed agendas and registration information, visit http://www.ISPE.org/2013-Supply-Chain-EU-Conference.
ISPE, the International Society for Pharmaceutical Engineering is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit http://www.ISPE.org for more information.
Read the full story at http://www.prweb.com/releases/2013/5/prweb10682241.htm.
Copyright©2012 Vocus, Inc.
All rights reserved